Hubei Jumpcan Pharmaceutical Co., Ltd.
600566
Pozycja w akcjach
#4335
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the... Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
Cena akcji
$3.87
Kapitalizacja rynkowa
$3.57B
Zmiana (1 dzień)
-1.64%
Zmiana (1 rok)
9.08%
Kraj
CN
Handel Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Kategoria
Healthcare
EPS dla Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy Hubei Jumpcan Pharmaceutical Co., Ltd., obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla Hubei Jumpcan Pharmaceutical Co., Ltd. od 2001 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2025 | $0.28 | -27.03% |
| 2024 | $0.38 | -13.10% |
| 2023 | $0.44 | 23.01% |
| 2022 | $0.35 | 15.89% |
| 2021 | $0.31 | 30.32% |
| 2020 | $0.23 | -18.05% |
| 2019 | $0.29 | -5.49% |
| 2018 | $0.30 | 30.29% |
| 2017 | $0.23 | 37.74% |
| 2016 | $0.17 | 24.35% |
| 2015 | $0.14 | 25.23% |
| 2014 | $0.11 | -0.55% |
| 2013 | $0.11 | -1,295.60% |
| 2012 | $-0.01 | -200.00% |
| 2011 | $0.01 | -2.15% |
| 2010 | $0.01 | -12.26% |
| 2009 | $0.01 | 19.10% |
| 2008 | $0.01 | -17.59% |
| 2007 | $0.01 | 20.00% |
| 2006 | $0.01 | 18.42% |
| 2005 | $0.01 | 16.92% |
| 2004 | $0.01 | 0.00% |
| 2003 | $0.01 | -46.28% |
| 2002 | $0.01 | -22.93% |
| 2001 | $0.02 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
